Cargando…

MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis

Engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) is a technology for purifying specific genomic regions to facilitate identification of their associated molecules, including proteins, RNAs, and other genomic regions. In enChIP, the target genomic region is tagged with...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuno, Miyuki, Nagata, Shoko, Fujita, Toshitsugu, Fujii, Hodaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365529/
https://www.ncbi.nlm.nih.gov/pubmed/34409168
http://dx.doi.org/10.1093/biomethods/bpab013
_version_ 1783738726178881536
author Yuno, Miyuki
Nagata, Shoko
Fujita, Toshitsugu
Fujii, Hodaka
author_facet Yuno, Miyuki
Nagata, Shoko
Fujita, Toshitsugu
Fujii, Hodaka
author_sort Yuno, Miyuki
collection PubMed
description Engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) is a technology for purifying specific genomic regions to facilitate identification of their associated molecules, including proteins, RNAs, and other genomic regions. In enChIP, the target genomic region is tagged with engineered DNA-binding molecules, for example, a variant of the clustered regularly interspaced short palindromic repeats (CRISPR) system consisting of a guide RNA (gRNA) and a catalytically inactive form of Cas9 (dCas9). In this study, to increase the flexibility of enChIP and expand the range of target cells, we generated murine stem cell virus (MSCV)-based retroviral plasmids for expressing dCas9. We constructed MSCV-based retroviral plasmids expressing Streptococcus pyogenes dCas9 fused to a 3xFLAG-tag (3xFLAG-Sp-dCas9) and various drug resistance genes. We showed that by using these plasmids, it is feasible to purify target genomic regions with yields comparable to those reported using other systems. These systems might give enChIP users greater flexibility in choosing optimal systems for drug selection of transduced cells.
format Online
Article
Text
id pubmed-8365529
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-83655292021-08-17 MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis Yuno, Miyuki Nagata, Shoko Fujita, Toshitsugu Fujii, Hodaka Biol Methods Protoc New Materials Engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) is a technology for purifying specific genomic regions to facilitate identification of their associated molecules, including proteins, RNAs, and other genomic regions. In enChIP, the target genomic region is tagged with engineered DNA-binding molecules, for example, a variant of the clustered regularly interspaced short palindromic repeats (CRISPR) system consisting of a guide RNA (gRNA) and a catalytically inactive form of Cas9 (dCas9). In this study, to increase the flexibility of enChIP and expand the range of target cells, we generated murine stem cell virus (MSCV)-based retroviral plasmids for expressing dCas9. We constructed MSCV-based retroviral plasmids expressing Streptococcus pyogenes dCas9 fused to a 3xFLAG-tag (3xFLAG-Sp-dCas9) and various drug resistance genes. We showed that by using these plasmids, it is feasible to purify target genomic regions with yields comparable to those reported using other systems. These systems might give enChIP users greater flexibility in choosing optimal systems for drug selection of transduced cells. Oxford University Press 2021-07-09 /pmc/articles/PMC8365529/ /pubmed/34409168 http://dx.doi.org/10.1093/biomethods/bpab013 Text en © The Author(s) 2021. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle New Materials
Yuno, Miyuki
Nagata, Shoko
Fujita, Toshitsugu
Fujii, Hodaka
MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis
title MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis
title_full MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis
title_fullStr MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis
title_full_unstemmed MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis
title_short MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis
title_sort mscv-based retroviral plasmids expressing 3xflag-sp-dcas9 for enchip analysis
topic New Materials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365529/
https://www.ncbi.nlm.nih.gov/pubmed/34409168
http://dx.doi.org/10.1093/biomethods/bpab013
work_keys_str_mv AT yunomiyuki mscvbasedretroviralplasmidsexpressing3xflagspdcas9forenchipanalysis
AT nagatashoko mscvbasedretroviralplasmidsexpressing3xflagspdcas9forenchipanalysis
AT fujitatoshitsugu mscvbasedretroviralplasmidsexpressing3xflagspdcas9forenchipanalysis
AT fujiihodaka mscvbasedretroviralplasmidsexpressing3xflagspdcas9forenchipanalysis